China Galaxy Investment Management is a legal person-owned investment institution.
China Galaxy Investment Management is a legal person-owned investment institution.The company's business strategy is: to build a national industrial guidance fund management platform and domestic private equity investment fund leading enterprises, to become a powerful investment and financing platform to promote the financial industry to serve the real economy and implement the national development strategy.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 17, 2018
Eoroom Technology
|
Series A | ¥1.20B | Building Material | — |
Dec 11, 2018
Cryofocus Biotech
|
Series A | $2.90M | Health Care | — |
May 18, 2018
Yibohui
|
Series A | — | Health Care | — |
Sep 25, 2017
KeyPower
|
Angel | ¥3M | Automotive | — |
Jun 14, 2016
AIJIYIN.COM.CN
|
Series A | ¥20M | Health Care | Yes |
China Galaxy Investment Management has had 2 exits. China Galaxy Investment Management most notable exits include Cryofocus Biotech , KOTEI
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Dec 30, 2022 | Cryofocus Biotech | IPO | Health Care | Detail |
Dec 22, 2021 | KOTEI | M&A | Automotive | Detail |